Phibro Animal Health Corporation (PAHC)

Net profit margin

		Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net income	US$ in thousands	48,264	2,416	32,606	49,175	54,385
Revenue	US$ in thousands	1,296,220	1,017,680	977,889	942,300	833,350
Net profit margin		3.72%	0.24%	3.33%	5.22%	6.53%

June 30, 2025 calculation

Net profit margin = Net income ÷ Revenue
= $48,264K ÷ $1,296,220K
= 3.72%

The net profit margin of Phibro Animal Health Corporation has demonstrated a notable decline over the analyzed period from June 30, 2021 to June 30, 2024, followed by a slight recovery in 2025. Specifically, the margin decreased from 6.53% in 2021 to 5.22% in 2022, indicating a reduction in profitability relative to revenue. This downward trend continued into 2023, with the net profit margin reaching 3.33%, reflecting further erosion of profit efficiency. In the subsequent year, June 30, 2024, the margin sharply declined to 0.24%, signaling a significant deterioration in net profitability and potentially highlighting operational challenges, increased costs, or other adverse factors impacting net income margins. However, a modest recovery is observable in 2025, with the net profit margin increasing to 3.72%, suggesting a potential stabilization or improvement in profitability, although it remains below the levels observed in 2021 and 2022. Overall, the trend indicates a period of declining profitability over three years, punctuated by a brief improvement, warranting further investigation into underlying operational or market conditions affecting the company's bottom line.